Tumor lysis syndrome historical perspective: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}} {{AE}} {{MJK}} | {{CMG}} {{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
Tumor lysis syndrome was first discovered in 1929 in patients with chronic leukemia.<ref name="pmid15063817">{{cite journal| author=Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ| title=Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. | journal=Am J Med | year= 2004 | volume= 116 | issue= 8 | pages= 546-54 | pmid=15063817 | doi=10.1016/j.amjmed.2003.09.045 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15063817 }} </ref> Spontaneous tumor lysis syndrome was first discovered by Crittenden and Ackerman, in 1977.<ref name="pmid831657">{{cite journal| author=Crittenden DR, Ackerman GL| title=Hyperuricemic acute renal failure in disseminated carcinoma. | journal=Arch Intern Med | year= 1977 | volume= 137 | issue= 1 | pages= 97-9 | pmid=831657 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=831657 }} </ref> | Tumor lysis syndrome was first discovered in 1929 in patients with chronic leukemia.<ref name="pmid15063817">{{cite journal| author=Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ| title=Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome. | journal=Am J Med | year= 2004 | volume= 116 | issue= 8 | pages= 546-54 | pmid=15063817 | doi=10.1016/j.amjmed.2003.09.045 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15063817 }} </ref>Spontaneous tumor lysis syndrome was first discovered by Crittenden and Ackerman, in 1977.<ref name="pmid831657">{{cite journal| author=Crittenden DR, Ackerman GL| title=Hyperuricemic acute renal failure in disseminated carcinoma. | journal=Arch Intern Med | year= 1977 | volume= 137 | issue= 1 | pages= 97-9 | pmid=831657 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=831657 }} </ref> | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 14:06, 29 September 2015
|
Tumor lysis syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Tumor lysis syndrome historical perspective On the Web |
|
American Roentgen Ray Society Images of Tumor lysis syndrome historical perspective |
|
Risk calculators and risk factors for Tumor lysis syndrome historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Tumor lysis syndrome was first discovered in 1929 in patients with chronic leukemia.[1]Spontaneous tumor lysis syndrome was first discovered by Crittenden and Ackerman, in 1977.[2]
References
- ↑ Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ (2004). "Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome". Am J Med. 116 (8): 546–54. doi:10.1016/j.amjmed.2003.09.045. PMID 15063817.
- ↑ Crittenden DR, Ackerman GL (1977). "Hyperuricemic acute renal failure in disseminated carcinoma". Arch Intern Med. 137 (1): 97–9. PMID 831657.